Arkolith/Insider Trading/ATRS/Form 4

Graham Peter J

See RemarksANTARES PHARMA, INC. (ATRS) · full profile →Form 4 · filed May 26, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
3 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 24, 2022Disposed to issuer(D)124K$5.60$696K0
May 24, 2022Disposed to issuer(D)414K$5.60$2.3M0
May 24, 2022Disposed to issuer(D)202K$5.60$1.1M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 24, 2022Disposed to issuer(D)218K——0
May 24, 2022Disposed to issuer(D)177K——0
May 24, 2022Disposed to issuer(D)125K——0
May 24, 2022Disposed to issuer(D)254K——0
May 24, 2022Disposed to issuer(D)164K——0
May 24, 2022Disposed to issuer(D)213K——0
May 24, 2022Disposed to issuer(D)170K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-019789) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML